Former President and Chief Executive Officer and Director · Viridian Therapeutics, Inc. (VRDN)

Lee Rauch

A named executive officer of Viridian Therapeutics in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,779,054

Salary $22,542Stock awards $0Bonus $541,000

FY2020: $1,670,411

4th of 4 named executive officers at Viridian Therapeutics by FY2021 total.

4 named officers on file for Viridian Therapeutics, FY2021

Lee Rauch’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • VRDN’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Viridian Therapeutics’s whole pay program stands against its peers

  • Viridian Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on VRDN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2022 (DEF 14A).

Free

Get Lee Rauch’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Lee Rauch compensation by year

Viridian Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Viridian Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$256,436$22,542
Bonus$270,500$541,000
Stock awards$0$0
Option awards$1,139,677$307,926
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$3,798$907,557
Total$1,670,411$1,779,054

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Viridian Therapeutics, Inc. DEF 14A filed April 27, 2022, accession 0001193125-22-123908, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Viridian Therapeutics, Inc. filed document, accession 0001193125-22-123908. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2022.

$1.7M
$1.8M
FY20
FY21
SalaryBonusOption awardsAll other

Viridian Therapeutics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Jonathan ViolinFormer President, Chief Executive Officer and Director$17,408,538
Barrett KatzChief Medical Officer$8,167,089
Kristian HumerChief Financial and Business Officer$7,708,958
Lee Rauch · this pageFormer President and Chief Executive Officer and Director$1,779,054

The full Viridian Therapeutics compensation record

free company brief

This page is one person within Viridian Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Viridian Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Viridian Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Lee Rauch's compensation dossier · One-time report. No refunds.